Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

被引:130
|
作者
Dial, Sandra [1 ,2 ]
Kezouh, Abbas [4 ]
Dascal, Andre [2 ,3 ]
Barkun, Alan [1 ,5 ,6 ]
Suissa, Samy [2 ,4 ]
机构
[1] McGill Univ, Dept Med, Montreal Chest Inst, Montreal, PQ H2X 2P4, Canada
[2] McGill Univ, Dept Med, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H2X 2P4, Canada
[3] McGill Univ, Div Infect Dis, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H2X 2P4, Canada
[4] McGill Univ, Ctr Clin Epidemiol, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H2X 2P4, Canada
[5] McGill Univ, Ctr Hlth, Div Gastroenterol, Montreal, PQ H2X 2P4, Canada
[6] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H2X 2P4, Canada
关键词
D O I
10.1503/cmaj.071812
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous observations have indicated that infection with Clostridium difficile occurs almost exclusively after exposure to antibiotics, but more recent observations have suggested that prior antibiotic exposure may be less frequent among cases of community-acquired disease. Methods: We used 2 linked health databases to perform a matched, nested case-control study of elderly patients admitted to hospital with community-acquired C. difficile infection. For each of 836 cases among people 65 years of age or older, we selected 10 controls. We determined the proportion of cases that occurred without prior antibiotic exposure and estimated the risk related to exposure to different antibiotics and the duration of increased risk. Results: Of the 836 cases, 442 (52.9%) had no exposure to antibiotics in the 45-day period before the index date, and 382 (45.7%) had no exposure in the 90-day period before the index date. Antibiotic exposure was associated with a rate ratio (RR) of 10.6 (95% confidence interval [CI] 8.9-12.8). Clindamycin (RR 31.8, 95% CI 17.6-57.6), cephalosporins (RR 14.9, 95% CI 10.9-20.3) and gatifloxacin (RR 16.7, 95% CI 8.3-33.6) were associated with the highest risk. The RR for C. difficile infection associated with antibiotic exposure declined from 15.4 (95% CI 12.2-19.3) by about 20 days after exposure to 3.2 (95% CI 2.0-5.0) after 45 days. Use of a proton pump inhibitor was associated with increased risk (RR 1.6, 95% CI 1.3-2.0), as were concurrent diagnoses of inflammatory bowel disease (RR 4.1, 95% CI 2.6-6.6), irritable bowel syndrome (RR 3.4, 95% CI 2.3-5.0) and renal failure (RR 1.7, 95% CI 1.2-2.2). Interpretation: Community-acquired C. difficile infection occurred in a substantial proportion of individuals with no recent exposure to antibiotics. Among patients who had been exposed to antibiotics, the risk declined markedly by 45 days after discontinuation of use.
引用
收藏
页码:767 / 772
页数:6
相关论文
共 50 条
  • [21] Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study
    Yoon Hee Park
    Jong Mi Seong
    Soyeon Cho
    Hye Won Han
    Jae Youn Kim
    Sook Hee An
    Hye Sun Gwak
    Journal of Gastroenterology, 2019, 54 : 1052 - 1060
  • [22] Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study
    Park, Yoon Hee
    Seong, Jong Mi
    Cho, Soyeon
    Han, Hye Won
    Kim, Jae Youn
    An, Sook Hee
    Gwak, Hye Sun
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (12) : 1052 - 1060
  • [23] Predictors of asymptomatic Clostridium difficile colonization on hospital admission
    Kong, Ling Yuan
    Dendukuri, Nandini
    Schiller, Ian
    Bourgault, Anne-Marie
    Brassard, Paul
    Poirier, Louise
    Lamothe, Francois
    Beliveau, Claire
    Michaud, Sophie
    Turgeon, Nathalie
    Toye, Baldwin
    Frost, Eric H.
    Gilca, Rodica
    Dascal, Andre
    Loo, Vivian G.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2015, 43 (03) : 248 - 253
  • [24] Clostridium difficile Infection Following Spine Surgery Incidence, Risk Factors, and Association With Preoperative Antibiotic Use
    Bell, Joshua
    Vatani, Jasmine
    Raad, Micheal
    Labaran, Lawal
    Puvanesarajah, Varun
    Hassanzadeh, Hamid
    SPINE, 2020, 45 (22) : 1572 - 1579
  • [25] Antibiotic Treatment for Clostridium difficile Infection in Adults
    Wilson, Amanda
    AMERICAN JOURNAL OF NURSING, 2018, 118 (07) : 63 - 63
  • [26] Statins use and risk of mortality in patient with Clostridium difficile infection
    Saliba, W.
    Barnett-Griness, O.
    Elias, M.
    Rennert, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : 1061 - 1066
  • [27] SPECIFIC HOSPITAL ROOMS ARE ASSOCIATED WITH INCREASED RISK FOR CLOSTRIDIUM DIFFICILE INFECTION
    Freedberg, Daniel E.
    Salmasian, Hojjat
    Wang, Timothy C.
    Abrams, Julian A.
    GASTROENTEROLOGY, 2017, 152 (05) : S345 - S345
  • [28] Hospital Transfer Network Structure as a Risk Factor for Clostridium difficile Infection
    Simmering, Jacob E.
    Polgreen, Linnea A.
    Campbell, David R.
    Cavanaugh, Joseph E.
    Polgreen, Philip M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (09): : 1031 - 1037
  • [29] Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel
    Na'amnih, Wasef
    Adler, Amos
    Miller-Roll, Tamar
    Cohen, Dani
    Carmeli, Yehuda
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (07) : 1281 - 1288
  • [30] Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel
    Wasef Na’amnih
    Amos Adler
    Tamar Miller-Roll
    Dani Cohen
    Yehuda Carmeli
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1281 - 1288